# Clonidine

## CataPRES 75mcg

##### 

| TAH Drug Code      | [OCAT](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OCAT)                                                                                                                                                                                                                       |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | All grades of hypertension except when due to pheochromocytoma.                                                                                                                                                                                                                            |
| Dosing             | HTN: Mild to moderate HTN: initial 0.075mg -0.15mg BID, may up to 0.3mg/day severe HTN: initial 0.3mg TID (0.9mg/day)                                                                                                                                                                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                              |
| Contraindications  | Sick-sinus syndrome. 2nd or 3rd degree AV block.                                                                                                                                                                                                                                           |
| Adverse Effects    | Initially, dry mouth & fatigue; orthostatic complaints especially with IV. Dermatologic: Contact dermatitis (5% to 47% ), Erythema (26% ), Pruritus Gastrointestinal: Xerostomia (25% ) Neurologic: Dizziness (2% ), Headache (5% ), Sedated (3% ), Somnolence (12% ) Other: Fatigue (6% ) |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Risk                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                              |

